JP2021526853A5 - - Google Patents

Info

Publication number
JP2021526853A5
JP2021526853A5 JP2021518031A JP2021518031A JP2021526853A5 JP 2021526853 A5 JP2021526853 A5 JP 2021526853A5 JP 2021518031 A JP2021518031 A JP 2021518031A JP 2021518031 A JP2021518031 A JP 2021518031A JP 2021526853 A5 JP2021526853 A5 JP 2021526853A5
Authority
JP
Japan
Prior art keywords
dna sequence
target dna
sequence
rgn
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021518031A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021526853A (ja
JP7708660B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/035373 external-priority patent/WO2019236566A1/en
Publication of JP2021526853A publication Critical patent/JP2021526853A/ja
Publication of JP2021526853A5 publication Critical patent/JP2021526853A5/ja
Priority to JP2025113206A priority Critical patent/JP2025133875A/ja
Application granted granted Critical
Publication of JP7708660B2 publication Critical patent/JP7708660B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021518031A 2018-06-05 2019-06-04 Rna誘導型ヌクレアーゼ、その活性な断片とバリアント、ならびに利用法 Active JP7708660B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025113206A JP2025133875A (ja) 2018-06-05 2025-07-03 Rna誘導型ヌクレアーゼ、その活性な断片とバリアント、ならびに利用法

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
US201862680862P 2018-06-05 2018-06-05
US201862680846P 2018-06-05 2018-06-05
US201862680853P 2018-06-05 2018-06-05
US201862680859P 2018-06-05 2018-06-05
US201862680863P 2018-06-05 2018-06-05
US201862680845P 2018-06-05 2018-06-05
US62/680,859 2018-06-05
US62/680,862 2018-06-05
US62/680,853 2018-06-05
US62/680,845 2018-06-05
US62/680,846 2018-06-05
US62/680,863 2018-06-05
US201862686901P 2018-06-19 2018-06-19
US62/686,901 2018-06-19
US201962805041P 2019-02-13 2019-02-13
US201962805045P 2019-02-13 2019-02-13
US62/805,045 2019-02-13
US62/805,041 2019-02-13
PCT/US2019/035373 WO2019236566A1 (en) 2018-06-05 2019-06-04 Rna-guided nucleases and active fragments and variants thereof and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025113206A Division JP2025133875A (ja) 2018-06-05 2025-07-03 Rna誘導型ヌクレアーゼ、その活性な断片とバリアント、ならびに利用法

Publications (3)

Publication Number Publication Date
JP2021526853A JP2021526853A (ja) 2021-10-11
JP2021526853A5 true JP2021526853A5 (cg-RX-API-DMAC7.html) 2022-06-10
JP7708660B2 JP7708660B2 (ja) 2025-07-15

Family

ID=67002401

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021518031A Active JP7708660B2 (ja) 2018-06-05 2019-06-04 Rna誘導型ヌクレアーゼ、その活性な断片とバリアント、ならびに利用法
JP2025113206A Pending JP2025133875A (ja) 2018-06-05 2025-07-03 Rna誘導型ヌクレアーゼ、その活性な断片とバリアント、ならびに利用法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025113206A Pending JP2025133875A (ja) 2018-06-05 2025-07-03 Rna誘導型ヌクレアーゼ、その活性な断片とバリアント、ならびに利用法

Country Status (19)

Country Link
US (4) US11162114B2 (cg-RX-API-DMAC7.html)
EP (2) EP4512900A3 (cg-RX-API-DMAC7.html)
JP (2) JP7708660B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210089629A (cg-RX-API-DMAC7.html)
CN (1) CN113015797A (cg-RX-API-DMAC7.html)
AU (2) AU2019282149B2 (cg-RX-API-DMAC7.html)
BR (1) BR112020024863A2 (cg-RX-API-DMAC7.html)
CA (1) CA3102840A1 (cg-RX-API-DMAC7.html)
DK (1) DK3802807T3 (cg-RX-API-DMAC7.html)
ES (1) ES3011849T3 (cg-RX-API-DMAC7.html)
FI (1) FI3802807T3 (cg-RX-API-DMAC7.html)
IL (2) IL321042A (cg-RX-API-DMAC7.html)
MX (1) MX2020013124A (cg-RX-API-DMAC7.html)
PL (1) PL3802807T3 (cg-RX-API-DMAC7.html)
PT (1) PT3802807T (cg-RX-API-DMAC7.html)
SG (1) SG11202011975WA (cg-RX-API-DMAC7.html)
TW (2) TW202532650A (cg-RX-API-DMAC7.html)
WO (1) WO2019236566A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202008045B (cg-RX-API-DMAC7.html)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9322037B2 (en) 2013-09-06 2016-04-26 President And Fellows Of Harvard College Cas9-FokI fusion proteins and uses thereof
US9340799B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College MRNA-sensing switchable gRNAs
EP3204496A1 (en) 2014-10-10 2017-08-16 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
WO2017070632A2 (en) 2015-10-23 2017-04-27 President And Fellows Of Harvard College Nucleobase editors and uses thereof
AU2017308889B2 (en) 2016-08-09 2023-11-09 President And Fellows Of Harvard College Programmable Cas9-recombinase fusion proteins and uses thereof
WO2018119359A1 (en) 2016-12-23 2018-06-28 President And Fellows Of Harvard College Editing of ccr5 receptor gene to protect against hiv infection
WO2018165504A1 (en) 2017-03-09 2018-09-13 President And Fellows Of Harvard College Suppression of pain by gene editing
KR20190123328A (ko) 2017-03-09 2019-10-31 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 암 백신
CN110914310A (zh) 2017-03-10 2020-03-24 哈佛大学的校长及成员们 胞嘧啶至鸟嘌呤碱基编辑器
IL306092A (en) 2017-03-23 2023-11-01 Harvard College Nucleic base editors that include nucleic acid programmable DNA binding proteins
US11560566B2 (en) 2017-05-12 2023-01-24 President And Fellows Of Harvard College Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
EP3652312A1 (en) 2017-07-14 2020-05-20 Editas Medicine, Inc. Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
EP3658573A1 (en) 2017-07-28 2020-06-03 President and Fellows of Harvard College Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace)
EP3676376B1 (en) 2017-08-30 2025-01-15 President and Fellows of Harvard College High efficiency base editors comprising gam
CA3082251A1 (en) 2017-10-16 2019-04-25 The Broad Institute, Inc. Uses of adenosine base editors
US12406749B2 (en) 2017-12-15 2025-09-02 The Broad Institute, Inc. Systems and methods for predicting repair outcomes in genetic engineering
WO2019226953A1 (en) 2018-05-23 2019-11-28 The Broad Institute, Inc. Base editors and uses thereof
AU2019291918B2 (en) 2018-06-29 2025-06-12 Editas Medicine, Inc. Synthetic guide molecules, compositions and methods relating thereto
EP3820495A4 (en) 2018-07-09 2022-07-20 The Broad Institute Inc. RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES
WO2020092453A1 (en) 2018-10-29 2020-05-07 The Broad Institute, Inc. Nucleobase editors comprising geocas9 and uses thereof
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
WO2020191241A1 (en) 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
WO2020214842A1 (en) 2019-04-17 2020-10-22 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
CN118813654A (zh) 2019-08-12 2024-10-22 生命编辑制药股份有限公司 Rna指导的核酸酶及其活性片段及变体以及使用方法
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
AU2020402526B2 (en) * 2019-12-10 2025-01-23 Inscripta, Inc. Novel MAD nucleases
EP4085133A1 (en) * 2019-12-30 2022-11-09 Lifeedit Therapeutics, Inc. Rna-guided nucleases and active fragments and variants thereof and methods of use
JP2023516226A (ja) * 2020-04-24 2023-04-18 ライフエディット セラピューティクス,インコーポレイティド Rna誘導型ヌクレアーゼとその活性な断片およびバリアント、ならびに利用の方法
WO2021222318A1 (en) * 2020-04-28 2021-11-04 The Broad Institute, Inc. Targeted base editing of the ush2a gene
CA3177481A1 (en) 2020-05-08 2021-11-11 David R. Liu Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
GB202007943D0 (en) 2020-05-27 2020-07-08 Snipr Biome Aps Products & methods
CN116194581A (zh) 2020-07-01 2023-05-30 艾勒维生技公司 使用环状rna进行细胞重编程的组合物和方法
JP7890972B2 (ja) 2020-07-15 2026-07-15 ライフ エディット セラピューティクス,インコーポレイティド ウラシル安定化タンパク質並びにその活性断片及びバリアント並びに使用方法
WO2022027035A1 (en) * 2020-07-27 2022-02-03 The Children's Hospital Of Philadelphia In utero and postnatal gene editing and therapy for treatment of monogenic diseases, including mucopolysaccharidosis type 1h and other disorders
EP4211235A2 (en) 2020-09-11 2023-07-19 Lifeedit Therapeutics, Inc. Dna modifying enzymes and active fragments and variants thereof and methods of use
AU2021409729A1 (en) 2020-12-22 2023-07-13 Nchroma Bio, Inc. Compositions and methods for epigenetic editing
CA3173950A1 (en) 2021-03-22 2022-09-22 Tyson D. BOWEN Dna modifyng enzymes and active fragments and variants thereof and methods of use
CA3173953A1 (en) 2021-06-11 2023-12-10 Tyson D. BOWEN Rna polymerase iii promoters and methods of use
KR20240150801A (ko) * 2022-02-23 2024-10-16 메타지노미, 인크. 카고 뉴클레오티드 서열을 전이시키기 위한 시스템 및 방법
CN114634923B (zh) * 2022-04-07 2024-02-23 尧唐(上海)生物科技有限公司 腺苷脱氨酶、碱基编辑器融合蛋白、碱基编辑器系统及用途
CN119836432A (zh) 2022-05-01 2025-04-15 恩科洛玛生物公司 用于pcsk9表达的表观遗传调节的组合物和方法
WO2023250148A1 (en) 2022-06-23 2023-12-28 Chroma Medicine, Inc. Compositions and methods for epigenetic editing
EP4544058A1 (en) 2022-06-23 2025-04-30 Chroma Medicine, Inc. Compositions and methods for epigenetic regulation of ciita expression
CA3260474A1 (en) 2022-06-23 2023-12-28 Chroma Medicine, Inc. COMPOSITIONS AND METHODS OF EPIGENETIC REGULATION OF B2M EXPRESSION
WO2023250490A1 (en) 2022-06-23 2023-12-28 Chroma Medicine, Inc. Compositions and methods for epigenetic regulation of trac expression
WO2024042489A1 (en) 2022-08-25 2024-02-29 LifeEDIT Therapeutics, Inc. Chemical modification of guide rnas with locked nucleic acid for rna guided nuclease-mediated gene editing
CN115820636B (zh) * 2022-09-02 2024-06-11 华南农业大学 靶向TP53基因的sgRNA及其应用
KR20250110209A (ko) 2022-09-23 2025-07-18 엔크로마 바이오, 인크. Hbv 유전자 발현의 에피제네틱 조절을 위한 조성물 및 방법
WO2024081879A1 (en) 2022-10-14 2024-04-18 Chroma Medicine, Inc. Compositions and methods for epigenetic regulation of cd247 expression
IL320573A (en) 2022-11-04 2025-07-01 Life Edit Therapeutics Inc Developed adenine deaminases and RNA-guided nuclease fusion proteins with internal insertion sites and methods of use
WO2024178397A2 (en) 2023-02-24 2024-08-29 Elevatebio Technologies, Inc. Modified immune effector cells and methods of use
JP2026523341A (ja) 2023-05-15 2026-07-14 エヌクロマ・バイオ,インコーポレーテッド Hbv遺伝子発現のエピジェネティック調節のための組成物および方法
WO2025174908A1 (en) 2024-02-12 2025-08-21 Life Edit Therapeutics, Inc. Novel rna-guided nucleases and proteins for polymerase editing
TW202617985A (zh) 2024-06-25 2026-05-01 美商生命編輯治療學公司 新穎反轉錄酶及其用途

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US457A (en) 1837-11-11 Caleb slade
US10167A (en) 1853-10-25 Soda-jountaiet
US699A (en) 1838-04-21 stone
US9840A (en) 1853-07-12 Improvement in tanning
US4217344A (en) 1976-06-23 1980-08-12 L'oreal Compositions containing aqueous dispersions of lipid spheres
US4196265A (en) 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4186183A (en) 1978-03-29 1980-01-29 The United States Of America As Represented By The Secretary Of The Army Liposome carriers in chemotherapy of leishmaniasis
US4261975A (en) 1979-09-19 1981-04-14 Merck & Co., Inc. Viral liposome particle
US4485054A (en) 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US5380831A (en) 1986-04-04 1995-01-10 Mycogen Plant Science, Inc. Synthetic insecticidal crystal protein gene
US4946787A (en) 1985-01-07 1990-08-07 Syntex (U.S.A.) Inc. N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5049386A (en) 1985-01-07 1991-09-17 Syntex (U.S.A.) Inc. N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US5569597A (en) 1985-05-13 1996-10-29 Ciba Geigy Corp. Methods of inserting viral DNA into plant material
US4774085A (en) 1985-07-09 1988-09-27 501 Board of Regents, Univ. of Texas Pharmaceutical administration systems containing a mixture of immunomodulators
US4853331A (en) 1985-08-16 1989-08-01 Mycogen Corporation Cloning and expression of Bacillus thuringiensis toxin gene toxic to beetles of the order Coleoptera
US5268463A (en) 1986-11-11 1993-12-07 Jefferson Richard A Plant promoter α-glucuronidase gene construct
US5608142A (en) 1986-12-03 1997-03-04 Agracetus, Inc. Insecticidal cotton plants
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5039523A (en) 1988-10-27 1991-08-13 Mycogen Corporation Novel Bacillus thuringiensis isolate denoted B.t. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
KR920701453A (ko) 1989-03-17 1992-08-11 미리엄 디. 멕코나헤이 유전자발현의 외부조절
ES2187497T3 (es) 1990-04-12 2003-06-16 Syngenta Participations Ag Promotores preferentemente en tejidos.
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
AU7979491A (en) 1990-05-03 1991-11-27 Vical, Inc. Intracellular delivery of biologically active substances by means of self-assembling lipid complexes
US5498830A (en) 1990-06-18 1996-03-12 Monsanto Company Decreased oil content in plant seeds
CA2051562C (en) 1990-10-12 2003-12-02 Jewel M. Payne Bacillus thuringiensis isolates active against dipteran pests
US5173414A (en) 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
US5399680A (en) 1991-05-22 1995-03-21 The Salk Institute For Biological Studies Rice chitinase promoter
JPH06510187A (ja) 1991-08-27 1994-11-17 ノバルティス アクチエンゲゼルシャフト 同翅類昆虫に対する殺虫性質を有したタンパク質及び植物保護におけるそれらの用法
TW261517B (cg-RX-API-DMAC7.html) 1991-11-29 1995-11-01 Mitsubishi Shozi Kk
US5587308A (en) 1992-06-02 1996-12-24 The United States Of America As Represented By The Department Of Health & Human Services Modified adeno-associated virus vector capable of expression from a novel promoter
US5814618A (en) 1993-06-14 1998-09-29 Basf Aktiengesellschaft Methods for regulating gene expression
US5789156A (en) 1993-06-14 1998-08-04 Basf Ag Tetracycline-regulated transcriptional inhibitors
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5608144A (en) 1994-08-12 1997-03-04 Dna Plant Technology Corp. Plant group 2 promoters and uses thereof
US5659026A (en) 1995-03-24 1997-08-19 Pioneer Hi-Bred International ALS3 promoter
US6072050A (en) 1996-06-11 2000-06-06 Pioneer Hi-Bred International, Inc. Synthetic promoters
ES2270227T3 (es) 1998-02-26 2007-04-01 Pioneer Hi-Bred International, Inc. Promotor met-1 del maiz.
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
CN1360632A (zh) 1999-05-04 2002-07-24 孟山都技术有限公司 鞘翅目毒性多肽组合物和抗虫转基因植物
BR0014516A (pt) 1999-09-15 2002-07-02 Monsanto Technology Llc Composições e métodos de uso de delta-endotoxina do bacilo thuringiensis ativo de lepidopteran
DK2359869T3 (en) 2001-12-17 2019-04-15 Univ Pennsylvania Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
US20050183161A1 (en) 2003-10-14 2005-08-18 Athenix Corporation AXMI-010, a delta-endotoxin gene and methods for its use
US7629504B2 (en) 2003-12-22 2009-12-08 Pioneer Hi-Bred International, Inc. Bacillus thuringiensis cry9 nucleic acids
ES2397118T3 (es) 2006-06-14 2013-03-04 Athenix Corporation AXMI-031, AXMI-039 ,AXMI-040 y AXMI-049, una familia de genes de endotoxina delta y métodos para su uso
ES2738980T3 (es) 2008-09-15 2020-01-28 Childrens Medical Ct Corp Modulación de BCL11A para el tratamiento de hemoglobinopatías
CN102648281B (zh) 2009-07-02 2017-04-05 阿森尼克斯公司 Axmi‑205杀虫基因和它的使用方法
US8586832B2 (en) 2009-12-21 2013-11-19 Pioneer Hi Bred International Inc Bacillus thuringiensis gene with Lepidopteran activity
CN103154247A (zh) 2010-08-19 2013-06-12 先锋国际良种公司 对鳞翅目昆虫具有活性的新苏云金杆菌基因
US9405700B2 (en) 2010-11-04 2016-08-02 Sonics, Inc. Methods and apparatus for virtualization in an integrated circuit
ES2728782T3 (es) 2012-05-25 2019-10-28 Univ California Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN
HUE051612T2 (hu) 2012-07-11 2021-03-01 Sangamo Therapeutics Inc Eljárások és készítmények lizoszomális tárolási betegségek kezelésére
EP3760719A1 (en) * 2013-11-18 2021-01-06 CRISPR Therapeutics AG Crispr-cas system materials and methods
US20150166984A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting alpha-antitrypsin point mutations
US10450584B2 (en) 2014-08-28 2019-10-22 North Carolina State University Cas9 proteins and guiding features for DNA targeting and genome editing
MX2017014560A (es) * 2015-05-15 2018-03-01 Pioneer Hi Bred Int Caracterizacion rapida de sistemas de endonucleasa cas, secuencias pam y elementos arn de guia.
US9790490B2 (en) 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
CN116555254A (zh) * 2015-10-09 2023-08-08 孟山都技术公司 新颖的rna导向性核酸酶及其用途
WO2017070632A2 (en) 2015-10-23 2017-04-27 President And Fellows Of Harvard College Nucleobase editors and uses thereof
EP3426780A1 (en) * 2016-03-11 2019-01-16 Pioneer Hi-Bred International, Inc. Novel cas9 systems and methods of use
US20190100762A1 (en) * 2016-03-11 2019-04-04 Pioneer Hi-Bred International, Inc. Novel cas9 systems and methods of use
US20190100745A1 (en) * 2016-06-20 2019-04-04 Pioneer Hi-Bred International, Inc. Novel cas systems and methods of use
WO2018027078A1 (en) 2016-08-03 2018-02-08 President And Fellows Of Harard College Adenosine nucleobase editors and uses thereof
WO2018035250A1 (en) * 2016-08-17 2018-02-22 The Broad Institute, Inc. Methods for identifying class 2 crispr-cas systems
KR20240007715A (ko) * 2016-10-14 2024-01-16 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵염기 에디터의 aav 전달
US11180778B2 (en) * 2016-11-11 2021-11-23 The Regents Of The University Of California Variant RNA-guided polypeptides and methods of use
CN113631704A (zh) * 2018-12-27 2021-11-09 生命编辑制药股份有限公司 可用于基因编辑的多肽及使用方法

Similar Documents

Publication Publication Date Title
JP2022545385A5 (cg-RX-API-DMAC7.html)
JP2022516130A5 (cg-RX-API-DMAC7.html)
JP2023516226A5 (cg-RX-API-DMAC7.html)
FI3802807T3 (fi) Rna-ohjattuja nukleaaseja ja niiden aktiivisia fragmentteja ja variantteja ja menetelmiä niiden käyttämiseksi
JP2021518139A5 (cg-RX-API-DMAC7.html)
CN103382468B (zh) 一种水稻基因组定点改造方法
JP2025013884A5 (cg-RX-API-DMAC7.html)
RU2017130143A (ru) Гибридные днк/рнк-полинукдеотиды crispr и способы
EP2864483B1 (en) Transcription activator-like effector assembly
FI4118198T3 (fi) Rna-ohjattuja nukleaaseja ja niiden aktiivisia fragmentteja ja variantteja ja käyttömenetelmiä
JP2025504898A5 (cg-RX-API-DMAC7.html)
CN105132451A (zh) 一种CRISPR/Cas9单一转录单元定向修饰骨架载体及其应用
JP2021501611A5 (cg-RX-API-DMAC7.html)
JP2016537008A5 (cg-RX-API-DMAC7.html)
JP2023533417A5 (cg-RX-API-DMAC7.html)
JP2017509350A5 (cg-RX-API-DMAC7.html)
JP2022530055A5 (cg-RX-API-DMAC7.html)
JP2021520800A5 (cg-RX-API-DMAC7.html)
JP2022524435A5 (cg-RX-API-DMAC7.html)
JP2022540153A5 (cg-RX-API-DMAC7.html)
CN104212836A (zh) 一种在哺乳动物细胞系中敲除mir-505的方法
US20190241911A1 (en) Engineered guide rna and uses thereof
CN106282173B (zh) 克隆转基因生物中外源基因整合位点处侧翼序列的方法
JP2023532665A5 (cg-RX-API-DMAC7.html)
CN103589743A (zh) Gibson组装载体及其制备方法和应用